Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T6IN
|
||||
Former ID |
DIB008293
|
||||
Drug Name |
Peginterferon lambda-1a
|
||||
Synonyms |
BMS-914143; IFN lambda, ZymoGenetics/Novo Nordisk; Interferon lambda 1, ZymoGenetics/Novo Nordisk; PEG-IL-29; PEG-rIL-29; Interleukin-29, ZymoGenetics/Novo Nordisk; PEG-IFN lambda, ZymoGenetics/Novo Nordisk; PEG-interferon lambda, ZymoGenetics/Novo Nordisk; PEGylated IL-29 (HCV infection), ZymoGenetics/Novo Nordisk; Peginterferon lambda-1a, ZymoGenetics/Bristol-Myers Squibb; PEG-IFN lambda, ZymoGenetics/Novo Nordisk/Bristol-Myers Squibb; PEG-interferon lambda, ZymoGenetics/Novo Nordisk/Bristol-Myers Squibb; Recombinant PEG-interferon lambda-1, ZymoGenetics/Bristol-Myers Squibb; PEGylated IL-29 (HCV infection), ZymoGenetics/Novo Nordisk/Bristol-Myers Squibb
|
||||
Indication | Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] | Phase 3 | [524307] | ||
Company |
Bristol-myers squibb
|
||||
CAS Number |
CAS 914617-98-4
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-29 ligand | Target Info | Agonist | [531043] | |
WikiPathways | Type III interferon signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.